Stock listing
Biogen Inc.
Selected listing: IDP · MUN · EUR · DE
Biogen Inc. (Munich:IDP), Health Technology. Latest release Oct 2, 2026: Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2…
- Ticker
- Munich:IDP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Munich
- Currency
- EUR
About Biogen Inc.
The company focuses on developing therapies for neurological diseases and has a strong portfolio of innovative treatments. Biogen is committed to advancing scientific research and improving patient outcomes in the field of neuroscience.
Latest news from Biogen Inc.
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 2, 2026
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 1, 2026
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
October 1, 2026
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
September 17, 2026
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
September 16, 2026
Events
Research Biogen Inc.
Alternate listings
BIIB:NASDAQ
US · USD
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
IDP:GETTEX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
BIIB:BCBA
AR · ARS
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
IDP:TRADEGATE
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
789617:LSX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
BIIB:BMV
MX · MXN
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
BIIBD:BCBA
AR · USD
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
789617:LS
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
BIIB:BCS
CL · USD
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
0R1B:LSE
GB · USD
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
IDP:FWB
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.
1BIIB:MIL
IT · EUR
Alternate listing for Biogen Inc.; the primary context on this page is IDP:MUN.